FWATX
Price
$14.46
Change
+$0.03 (+0.21%)
Updated
Jun 25 closing price
Net Assets
2.78B
RLBCX
Price
$35.92
Change
-$0.04 (-0.11%)
Updated
Jun 25 closing price
Net Assets
248.02B
Interact to see
Advertisement

FWATX vs RLBCX

Header iconFWATX vs RLBCX Comparison
Open Charts FWATX vs RLBCXBanner chart's image
Fidelity Advisor Multi-Asset Income A
Price$14.46
Change+$0.03 (+0.21%)
VolumeN/A
Net Assets2.78B
American Funds American Balanced R3
Price$35.92
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets248.02B
FWATX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FWATX vs. RLBCX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWATX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 248B vs. FWATX (2.78B). FWATX pays higher dividends than RLBCX: FWATX (3.68) vs RLBCX (1.63). FWATX was incepted earlier than RLBCX: FWATX (10 years) vs RLBCX (23 years). FWATX (1.09) is less costly to investors than RLBCX (0.89). FWATX is a more actively managed with annual turnover of: 230.00 vs. RLBCX (44.00). FWATX has a lower initial minimum investment than RLBCX: FWATX (0) vs RLBCX (250). FWATX annual gain was more profitable for investors over the last year : 7.01 vs. RLBCX (6.05). FWATX return over 5 years is better than : 53.14 vs. RLBCX (39.81).
FWATXRLBCXFWATX / RLBCX
Total Expense Ratio1.090.89122%
Annual Report Gross Expense Ratio1.090.89122%
Fund Existence10 years23 years-
Gain YTD3.8175.79666%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.78B248B1%
Annual Yield % from dividends3.681.63225%
Returns for 1 year7.016.05116%
Returns for 3 years29.4730.5596%
Returns for 5 years53.1439.81133%
Returns for 10 yearsN/A57.74-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN30.650.29
+0.96%
Citi Trends
IT402.642.25
+0.56%
Gartner
NTLA9.56-0.01
-0.10%
Intellia Therapeutics
VRRM25.01-0.18
-0.71%
Verra Mobility Corp
GBIO0.36-0.01
-1.51%
Generation Bio Co